References
- Hoeller U. Borgmann K, Bonacker M, et al. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol 2003;69:137-144 https://doi.org/10.1016/j.radonc.2003.10.001
- Rudat V, Dietz A, Conradt C, Flentje M. In vitro radiosensitivity of primary human fibroblasts: lack of correlation with acute radiation toxicity in patients with head and neck cancer. Radiother Oncol 1997;43:181-188 https://doi.org/10.1016/S0167-8140(97)01933-6
- Kiltie AE, Ryan AJ, Swindell R, et al. A correlation between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiotherapy reactions in breast cancer patients. Radiother Oncol 1999;51:55-65 https://doi.org/10.1016/S0167-8140(99)00030-4
- Casse C. Hu YC, Ahrendt SA. The XRCC1 codon 399 Gln allele is associated with adenine guanine p53 mutations in non-small cell lung cancer. Mutat Res 2003;25:19-27
- Zhou W, Liu G, Miller DP, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2003;12:359-365
- Smith TR, Miller MS, Lohman K, et al. Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett 2003;190: 183-190 https://doi.org/10.1016/S0304-3835(02)00595-5
- Thompson LH, Brookman KW, Jones NJ, Allen SA, Carrano AV. Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromitid exchange. Mol Cell Biol 1990;10:6160-6171 https://doi.org/10.1128/MCB.10.12.6160
- Lee SG, Kim B. Choi J, Kim C. Lee I. Song K. Genetic polymorphisms of XRCC1 and risk of gastric cancer. Cancer Lett 2002;187:53-60 https://doi.org/10.1016/S0304-3835(02)00381-6
- Lee JM. Lee YC. Yang SY, et al. Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int J Cancer 2001;95:240-246 https://doi.org/10.1002/1097-0215(20010720)95:4<240::AID-IJC1041>3.0.CO;2-1
- Caldecott KW, McKeown CK. Tucker JD, Ljunsquist S. Thompson LH. An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol Cell Biol 1994;14:68-76 https://doi.org/10.1128/MCB.14.1.68
- Gryk MR. Marintchev A. Maciejewski MW. Robertson A, Wilson SH. Mullen GP. Mapping of the interaction interface of DNA polymerase beta with XRCC1. Structure 2000;10:1709-1720 https://doi.org/10.1016/S0969-2126(02)00908-5
- Whitehouse CJ, Taylor RM, Thistlethwaite A. et al. XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell 2001;104:107-117 https://doi.org/10.1016/S0092-8674(01)00195-7
- Vidal AE, Boiteux S, Hickson ID, Radicella JP. XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J 2001;20:6530-6539 https://doi.org/10.1093/emboj/20.22.6530
- Shen MR. Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998;58:604-608
- Stoehlmacher J, Ghaderi V, lobal S, et al. A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. Anticancer Res 2001;21:3075-3079
- Cox JD, Stetz J. Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346 https://doi.org/10.1016/0360-3016(95)00060-C
- Lunn RM. Langlois RG, Hsieh LL. Thompson CI. Bell DA. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999;59:2557-2561
- Tuimala J, Szekely G, Gundy S, Hirvonen A, Norppa H. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis 2002;23:1003-1008 https://doi.org/10.1093/carcin/23.6.1003
- Caldecott KW. XRCC1 and DNA strand break repair. DNA Repair 2003;2:955-969 https://doi.org/10.1016/S1568-7864(03)00118-6
- Shen NR. Zdzienicka MZ, Mohrenweiser H, Thompson LH. Thelen MP. Mutations in hamster single-strand break repair gene XRCC1 causing defective DNA repair. Nucleic Acids Res 1998;26:1032-1037 https://doi.org/10.1093/nar/26.4.1032
- Churchill ME. Peak JG. Peak MJ. Correlation between cell-survival and DNA-strand break repair proficiency in the Chinese hamster ovary cell-lines AA8 and EM9 irradiated with 365-nm ultraviolet-a radiation. Photochem Photobiol 1991;53:229-236 https://doi.org/10.1111/j.1751-1097.1991.tb03927.x
- Fernet M, Hall J. Genetic biomarkers of therapeutic radiation sensitivity. DNA Repair 2004;3:1237-1243 https://doi.org/10.1016/j.dnarep.2004.03.019
- Moullan N. Cox DG, Angele S, Romenstaing P. Gerard JP. Hall J. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk and response to radiotherapy. Cancer Epidemiol Biomarkers Prev 2003;12:1168-1174
- Wang Y. Spitz MR. Zhu Y. Dong Q, Shete S. Wu X. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair 2003;2:901-908 https://doi.org/10.1016/S1568-7864(03)00085-5
- Borgmann K. Roper B, EI-Awady R, et al. Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. Radiother Oncol 2002;64:141-152 https://doi.org/10.1016/S0167-8140(02)00167-6
- Oppitz U. Schulte S. Stopper H. et al. In vitro radiosensitivity measured in lymphocytes and fibroblasts by colony formation and comet assay: comparison with clinical acute reactions to radiotherapy in breast cancer patients. Int J Radiat Biol 2002;78:611-616 https://doi.org/10.1080/09553000210126466
- Huyck KD, Eijkeren MV, Claes K, et al. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lvmphocytes. Int J Radiat Oncol Biol Phys 2005;62:1140-1149 https://doi.org/10.1016/j.ijrobp.2004.12.027
- Masson M, Niedergang C, Schreiber V, Muller S. Menissier-de Murcia J, de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose)polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 1998; 18:3563-3571 https://doi.org/10.1128/MCB.18.6.3563
- Duell EJ, Wieneke JK, Cheng T J, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000;21:965-971 https://doi.org/10.1093/carcin/21.5.965
- Lunn RM. Langlois RG, Hsieh LL. Thompson CL, Bell DA. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999;59:2557-2561
- Hu JJ, Smith TR, Miller MS, Lohman K, Case LD. Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ Mol Mutagen 2002;39:208-215 https://doi.org/10.1002/em.10058
- Hu JJ. Smith TR, Miller MS, Mohrenweiser HW, Golden A. Case LD. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 2001;22:917-922 https://doi.org/10.1093/carcin/22.6.917
- Krajinovic M, Labuda D. Mathonnet G, et al. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia. Clin Cancer Res 2002;8:802-810
- Liu D, O'Day SJ. Yang D, et al. Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochemotherapy: an exploratory study. Clin Cancer Res 2005;11:1237-1246
- Sak SC, Harnden P, Johnston CF. Paul AB, Kiltie AE. APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer. Clin Cancer Res 2005;11:6205-6211 https://doi.org/10.1158/1078-0432.CCR-05-0045
- Gurubhagavatula S, Liu G. Park S, et al. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol 2004;22:2519-2521 https://doi.org/10.1200/JCO.2004.04.900